Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
free free
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Cytotoxicity mediated by histone deacetylase inhibitors in cancer cells: mechanisms and potential clinical implications Schrump DSClin Cancer Res 2009[Jun]; 15 (12): 3947-57Aberrant expression of epigenetic regulators of gene expression contributes to initiation and progression of cancer. During recent years, considerable research efforts have focused on the role of histone acetyltransferases (HATs) and histone deacetylases (HDACs) in cancer cells, and the identification of pharmacologic agents that modulate gene expression via inhibition of HDACs. The following review highlights recent studies pertaining to HDAC expression in cancer cells, the plieotropic mechanisms by which HDAC inhibitors (HDACi) mediate antitumor activity, and the potential clinical implications of HDAC inhibition as a strategy for cancer therapy.|*Histone Deacetylase Inhibitors[MESH]|Antibiotics, Antineoplastic/*therapeutic use[MESH]|Autophagy[MESH]|DNA Methylation/drug effects[MESH]|Depsipeptides/metabolism[MESH]|Enzyme Inhibitors/*therapeutic use[MESH]|Epigenesis, Genetic/drug effects[MESH]|Gene Expression Regulation, Neoplastic/drug effects[MESH]|Histone Acetyltransferases/*antagonists & inhibitors[MESH]|Humans[MESH]|Neoplasms/drug therapy/*enzymology[MESH] |